Brian Leuthner

Founder at Alivio Therapeutics, Inc.

Net worth: - $ as of 2024-03-30

59 year

35 connections

Health Technology

Health Services

Consumer Services

Brian Leuthner active positions

Companies	Position	Start	End
Alivio Therapeutics, Inc. Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA.	Director/Board Member	-	-
	Founder	-	-
	President	-	-
	Chief Executive Officer	-	-

Career history of Brian Leuthner

Former positions of Brian Leuthner

Companies	Position	Start	End
ONCOSEC MEDICAL INCORPORATED	Chief Executive Officer	2021-06-23	2021-08-12
ONCOSEC MEDICAL INCORPORATED	Chief Operating Officer	2021-02-01	2021-08-12
Fontus Pharmaceuticals, Inc.	Chief Executive Officer	2006-12-31	2007-12-31
THE MEDICINES COMPANY	Sales & Marketing	2004-12-31	2006-12-31
ESP Pharma, Inc. ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ	Corporate Officer/Principal	2002-12-31	2004-12-31
PDS BIOTECHNOLOGY CORPORATION	Chief Executive Officer	-	-
Ortho Biotech Products LP Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ	Corporate Officer/Principal	-	-
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Director/Board Member	2009-01-21	-
	Chief Executive Officer	2009-01-21	-
	Founder	2009-01-21	-
	President	2009-01-21	-

Training of Brian Leuthner

The University of North Carolina at Chapel Hill

Masters Business Admin

Statistics

International

United States

Operational

Chief Executive Officer	5
Director/Board Member	2
Founder	2

Sectoral

Health Technology	7
Health Services	2
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	2
ONCOSEC MEDICAL INCORPORATED	Health Services
PDS BIOTECHNOLOGY CORPORATION	Health Technology

Private companies	6
The Medicines Co. The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.	Health Technology
ESP Pharma, Inc. ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ	Health Technology
Edge Therapeutics, Inc. Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ.	Health Technology
Ortho Biotech Products LP Ortho Biotech Products LP Pharmaceuticals: MajorHealth Technology Ortho Biotech Products LP provides innovative products and services which are designed to enhance the lives of individuals with serious chronic illnesses. The company's products include PROCRIT, DOXIL and LEUSTATIN. Ortho Biotech Products was founded in 1990 and is headquartered in Bridgewater, NJ	Health Technology
Fontus Pharmaceuticals, Inc.
Alivio Therapeutics, Inc. Alivio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA.	Health Technology

See company connections